Showing results (1-10 of 157) with videos related to
Sort By:
Pageof 16
Blood Advances|February 9, 2021
Adenylate kinase 2 expression and addiction in T-ALLNabih Maslah, Mehdi Latiri, Vahid Asnafi, et al.Best Practice & Research. Clinical Haematology|February 8, 2005
Clinical impact of molecular diagnostics in low-grade lymphomaMariem Bahloul, Vahid Asnafi, Elizabeth MacintyreInternational Journal of Cancer|January 3, 2025
Neo-enhancers in T-cell acute lymphoblastic Leukaemia (T-ALL) and beyondCharlotte Smith, Vahid Asnafi, Aurore TouzartMolecular Cancer Research : MCR|February 14, 2018
BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal TransitionGuillaume P Andrieu, Gerald V DenisBlood|June 14, 2021
PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALLGuillaume P Andrieu, Milena Kohn, Mathieu Simonin, et al.Nature Communications|March 4, 2025
A metabolic synthetic lethality of phosphoinositide 3-kinase-driven cancerGuillaume P Andrieu, Mathieu Simonin, Aurélie Cabannes-Hamy, et al.Blood|May 2, 2009
TGF-beta induces degradation of TAL1/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylationJean-Michel Terme, Ludovic Lhermitte, Vahid Asnafi, et al.Blood|August 26, 2025
LEF1 Intragenic Deletion Induces a Dominant-Negative isoform and unveils a Wnt/β3-Catenin Vulnerability in T-ALLManon Delafoy, Mickaël Frédéric Bonnet, Etienne Lengliné, et al.Science Translational Medicine|May 27, 2021
Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroupAurore Touzart, Anand Mayakonda, Charlotte Smith, et al.Pageof 16